November 24, 2021 South Korea’s Enzychem to make Indian drugmaker Cadila’s COVID-19 shot Explore further
November 8, 2021 Enzychem Files for FDA Breakthrough Therapy Designation for EC-18 for the Treatment of Chemoradiation-Induced Oral Mucositis Explore further
October 29, 2021 EC-18 Improves Length and Frequency of Chemoradiation-Induced Oral Mucositis in Head and Neck Cancer Explore further
October 21, 2021 EC-18 Reduces Duration and Incidence of Chemoradiation-Induced Oral Mucositis in Head and Neck Cancer Explore further
October 21, 2021 EC-18 Yields Positive Results for Chemoradiation-Induced Oral Mucositis in Head and Neck Cancer Explore further
October 20, 2021 Enzychem’s EC-18 reduces occurrence of oral mucositis in Phase II trial Explore further